IMPAX LABORATORIES, INC.
Patent Owner
Stats
- 15 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Feb 27, 2018 most recent publication
Details
- 15 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,184 Total Citation Count
- Aug 18, 1997 Earliest Filing
- 18 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9901640 Controlled release formulations of levodopa and uses thereofDec 19, 16Feb 27, 18[A61K, C07C]
9533046 Controlled release formulations of levodopa and uses thereofDec 04, 15Jan 03, 17[A61K, C07C]
9463246 Controlled release formulations of levodopa and uses thereofSep 18, 13Oct 11, 16[A61K, C07C]
9089607 Controlled release formulations of levodopa and uses thereofMay 22, 13Jul 28, 15[A61K, C07C]
9089608 Controlled release formulations of levodopa and uses thereofSep 18, 13Jul 28, 15[A61K, C07C]
8007827 Pharmaceutical dosage forms having immediate release and/or controlled release propertiesSep 30, 05Aug 30, 11[A61K]
7094427 Combination immediate release controlled release levodopa/carbidopa dosage formsSep 12, 02Aug 22, 06[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0064,896 Gastroretentive Solid Oral Dosage Forms with Swellable Hydrophilic PolymerAbandonedDec 28, 10Mar 14, 13[A61J, A61K]
2010/0166,857 PHARMACEUTICAL DOSAGE FORMS AND METHODS OF MANUFACTURING SAMEAbandonedDec 30, 09Jul 01, 10[A61K, B05D, A61P]
2010/0040,680 MULTIPARTICULATE SELECTIVE SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITOR FORMULATIONAbandonedAug 15, 08Feb 18, 10[A61K]
2009/0214,665 Controlled Release Muscarinic Receptor Antagonist FormulationAbandonedFeb 26, 08Aug 27, 09[A61K, A61P]
2006/0013,875 Combination immediate release controlled release levodopa/carbidopa dosage formsAbandonedAug 02, 05Jan 19, 06[A61K]
2005/0226,927 Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABAB receptor agonistAbandonedMay 26, 05Oct 13, 05[A61K]
2005/0220,863 Pharmaceutical dosage forms having controlled release properties that contain a GABAB receptor agonistAbandonedApr 02, 04Oct 06, 05[A61K]
2005/0220,864 Pharmaceutical dosage forms having controlled release properties that contain a GABAB receptor agonistAbandonedApr 02, 04Oct 06, 05[A61K]
2005/0220,873 Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonistAbandonedApr 02, 04Oct 06, 05[A61K]
2005/0220,874 Pharmaceutical dosage forms having immediate release and controlled release properties that contain a GABAB receptor agonistAbandonedApr 02, 04Oct 06, 05[A61K]
2004/0166,159 Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopaAbandonedFeb 27, 04Aug 26, 04[A61K]
2004/0097,484 Once a day galantamine pharmaceutical compositions and methods of useAbandonedNov 14, 02May 20, 04[A61K]
2004/0044,023 Compositions and methods for treating or preventing memory impairmentAbandonedAug 30, 02Mar 04, 04[A61K]
2003/0224,045 Combination immediate release sustained release levodopa/carbidopa dosage formsAbandonedMay 29, 02Dec 04, 03[A61K]
2003/0203,028 Multiplex drug delivery system suitable for oral administrationAbandonedMay 12, 03Oct 30, 03[A61K]
6531158 Drug delivery system for enhanced bioavailability of hydrophobic active ingredientsExpiredAug 09, 00Mar 11, 03[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.